Free Trial
OTCMKTS:VICP

Vicapsys Life Sciences (VICP) Stock Price, News & Analysis

Vicapsys Life Sciences logo
$1.51
0.00 (0.00%)
(As of 10/31/2024 ET)

About Vicapsys Life Sciences Stock (OTCMKTS:VICP)

Key Stats

Today's Range
$1.51
$1.51
50-Day Range
$1.51
$1.51
52-Week Range
$0.42
$14.00
Volume
N/A
Average Volume
874 shs
Market Capitalization
$48.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.

Receive VICP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

VICP Stock News Headlines

Anavex Life Sciences Corp AVXL
Banking failure dead ahead
If you missed it, my emergency election broadcast is now available - but will be removed soon
VICP - Vicapsys Life Sciences, Inc.
ViCapsys Life Sciences Appoints Three New Board Members
See More Headlines

VICP Stock Analysis - Frequently Asked Questions

Vicapsys Life Sciences' stock was trading at $2.74 at the beginning of 2024. Since then, VICP shares have decreased by 44.9% and is now trading at $1.51.
View the best growth stocks for 2024 here
.

Vicapsys Life Sciences, Inc. (OTCMKTS:VICP) issued its quarterly earnings data on Monday, October, 21st. The company reported ($0.01) earnings per share (EPS) for the quarter.

Shares of VICP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vicapsys Life Sciences investors own include Vapotherm (VAPO), Reliance Global Group (RELI), NLS Pharmaceutics (NLSP), Meta Platforms (META), Fantex (EJMLL), Digital Transformation Opportunities (DTOCU) and Comtech Telecommunications (CMTL).

Company Calendar

Last Earnings
10/21/2024
Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:VICP
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.06) per share

Miscellaneous

Free Float
30,435,000
Market Cap
$48.43 million
Optionable
Not Optionable
Beta
-4.14
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report

This page (OTCMKTS:VICP) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners